INGALLS & SNYDER LLC - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 61 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
INGALLS & SNYDER LLC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q4 2020$1,215,000
+6.5%
1,115,000
-0.3%
0.06%
-23.1%
Q3 2020$1,141,000
-7.8%
1,118,000
-0.5%
0.08%
+9.9%
Q2 2020$1,237,000
+8.1%
1,124,000
-0.2%
0.07%
-7.8%
Q1 2020$1,144,000
-11.0%
1,126,0000.0%0.08%
+10.0%
Q4 2019$1,285,000
+0.2%
1,126,0000.0%0.07%
+11.1%
Q3 2019$1,282,000
-8.4%
1,126,000
-4.7%
0.06%
-6.0%
Q2 2019$1,400,000
-11.9%
1,182,000
+0.7%
0.07%
-11.8%
Q1 2019$1,589,000
+11.2%
1,174,000
-11.9%
0.08%
+1.3%
Q4 2018$1,429,0001,332,0000.08%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q3 2019
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 9,821,000$11,314,0001.07%
TFG Asset Management GP Ltd 6,000,000$6,883,0001.02%
Alken Asset Management Ltd 400,000$461,0000.79%
Lombard Odier Asset Management (Europe) Ltd 6,525,000$7,470,0000.54%
CSS LLC/IL 8,000,000$9,158,0000.51%
IRON Financial LLC 505,000$578,0000.28%
MACKAY SHIELDS LLC 32,796,000$37,597,0000.26%
OSTRUM ASSET MANAGEMENT 400$459,0000.22%
RWC Asset Management LLP 4,400,000$5,037,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 4,871,000$5,580,0000.16%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders